90 related articles for article (PubMed ID: 6208504)
1. Treatment of non-fluctuating progressive dystonia: a neuropharmacological approach.
Willemse J; van Nieuwenhuizen O; Gooskens RH; Westenberg HG
Neuropediatrics; 1984 Oct; 15(4):208-10. PubMed ID: 6208504
[TBL] [Abstract][Full Text] [Related]
2. Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia.
Abeling NG; Duran M; Bakker HD; Stroomer L; Thöny B; Blau N; Booij J; Poll-The BT
Mol Genet Metab; 2006; 89(1-2):116-20. PubMed ID: 16650784
[TBL] [Abstract][Full Text] [Related]
3. [A study on catecholamine metabolites in CSF in a patient with progressive dystonia with marked diurnal fluctuation].
Maekawa N; Hashimoto T; Sasaki M; Oishi T; Tsuji S
Rinsho Shinkeigaku; 1988 Oct; 28(10):1206-8. PubMed ID: 2464453
[No Abstract] [Full Text] [Related]
4. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
[TBL] [Abstract][Full Text] [Related]
5. Selective decrease in central nervous system serotonin turnover in children with dopa-nonresponsive dystonia.
Assmann B; Köhler M; Hoffmann GF; Heales S; Surtees R
Pediatr Res; 2002 Jul; 52(1):91-4. PubMed ID: 12084853
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol.
Rüther E; Schilkrut R; Ackenheil M; Eben E; Hippius H
Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):33-6. PubMed ID: 981320
[TBL] [Abstract][Full Text] [Related]
7. Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.
Campanella G; Algeri S; Cerletti C; Dolfini E; Jori A; Rinaldi F
Eur J Clin Pharmacol; 1977 Apr; 11(4):255-61. PubMed ID: 862646
[No Abstract] [Full Text] [Related]
8. [Cerebrospinal fluid amine metabolites and L-dopa in vegetative state patients (author's transl)].
Inagawa T; Ishikawa S; Uozumi T
No Shinkei Geka; 1978 Mar; 6(3):235-43. PubMed ID: 643153
[No Abstract] [Full Text] [Related]
9. Diminished ventricular fluid dopamine metabolites in adult-onset dystonia.
Tabaddor K; Wolfson LI; Sharpless NS
Neurology; 1978 Dec; 28(12):1254-8. PubMed ID: 569784
[TBL] [Abstract][Full Text] [Related]
10. 14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa.
Extein I; Van Woert M; Roth RH; Bowers MB
Biol Psychiatry; 1976 Apr; 11(2):227-32. PubMed ID: 971447
[TBL] [Abstract][Full Text] [Related]
11. [HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data].
Carrieri P; Mandarini A; Campanella G
Acta Neurol (Napoli); 1975; 30(5):449-54. PubMed ID: 132845
[No Abstract] [Full Text] [Related]
12. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
Cramer H; Warter JM; Renaud B
Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
[No Abstract] [Full Text] [Related]
13. Clinical and biochemical parameters during neuroleptic treatment. II. Antipsychotic effect of haloperidol in patients with chronic organic brain damage.
Schilkrut R; Rüther E; Ackenheil M; Eben E; Hippius H
Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):37-42. PubMed ID: 981321
[TBL] [Abstract][Full Text] [Related]
14. [Cerebrospinal HVA and 5-HIAA in patients with endogenous depression in the course of treatment].
Loeb DC; Roccatagliata G; Albano C; Abbruzzese G
Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):27-32. PubMed ID: 6158092
[TBL] [Abstract][Full Text] [Related]
15. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (HIAA) in the CSF after administration of probenecid in Huntington's chorea. Effect of lithium carbonate].
Livrea P; Di Reda L; Ragno G; Germinario L; Papagno G
Riv Neurobiol; 1977; 23(3):149-59. PubMed ID: 154166
[No Abstract] [Full Text] [Related]
16. Bovine spastic paralysis: cerebrospinal fluid concentrations of homovanillic acid and 5-hydroxyindoleacetic acid in normal and spastic calves.
De Ley G; De Moor A
Am J Vet Res; 1975 Feb; 36(2):227-8. PubMed ID: 1111389
[TBL] [Abstract][Full Text] [Related]
17. Overnight sleep EEG and cerebrospinal fluid monoamines in seizures induced by movement.
Fukuyama Y; Ochiai Y; Hayakawa T; Miyagawa F
Neuropadiatrie; 1979 May; 10(2):138-49. PubMed ID: 226908
[TBL] [Abstract][Full Text] [Related]
18. [5-HIAA and HVA levels in the cerebrospinal fluid of hydrocephalic patients].
Massarotti M; Migliore A; Roccella P; Toffano G
Acta Neurol (Napoli); 1976; 31(5):601-13. PubMed ID: 1015383
[No Abstract] [Full Text] [Related]
19. Homovanillic acid and 5-hydroxyindole-acetic acid in the csf of patients after a severe head injury. I. Lumbar csf concentration in chronic brain post-traumatic syndromes.
Bareggi SR; Porta M; Selenati A; Assael BM; Calderini G; Collice M; Rossanda M; Morselli PL
Eur Neurol; 1975; 13(6):528-44. PubMed ID: 1193100
[TBL] [Abstract][Full Text] [Related]
20. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) levels in the lumbar cerebrospinal fluid in epileptic patients].
Livrea P; Di Reda L; Puca FM; Genco S; Specchio L; Papagno G
Boll Soc Ital Biol Sper; 1976 Jun; 52(11):800-5. PubMed ID: 1016632
[No Abstract] [Full Text] [Related]
[Next] [New Search]
